lithium carbonate has been researched along with Myeloproliferative Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berman, B; Dale, DC; Hammond, WP; Wright, DG | 1 |
| Borsotti, M; Fanci, R; Valenza, T | 1 |
2 other study(ies) available for lithium carbonate and Myeloproliferative Disorders
| Article | Year |
|---|---|
Lithium is an ineffective therapy for human cyclic hematopoiesis.
Topics: Enuresis; Hematopoiesis; Humans; Leukocyte Count; Lithium; Lithium Carbonate; Myeloproliferative Disorders; Neutrophils; Periodicity | 1983 |
The role of lithium carbonate in the management of hemolymphoblastosis: estimation of plasmatic and erythrocyte lithium levels.
Topics: Antineoplastic Combined Chemotherapy Protocols; Erythrocytes; Hematopoiesis; Humans; Lithium; Lithium Carbonate; Myeloproliferative Disorders | 1985 |